Is TENX or TLX more undervalued in 2026?

CirclFi compares Tenax Therapeutics, Inc. (TENX) and Telix Pharmaceuticals Limited (TLX) using 13 institutional-grade valuation models. TENX has a Quality of Company score of 4.5/10 while TLX scores 3.3/10.

Which is a better buy — TENX or TLX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do TENX and TLX valuations compare?

TENX at $11.69 and TLX at $9.53 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

TENX vs TLX Valuation Comparison 2026 — Intrinsic Value Analysis

TENX

Biotechnology

Tenax Therapeutics, Inc.

Quality

4.5

out of 10

Value Trap

LOW

Price

$11.69

Last close

Models

7/13

Active

TLX

Biotechnology

Telix Pharmaceuticals Limited

Quality

3.3

out of 10

Value Trap

—

Price

$9.53

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	TENX Fair Value	TENX Upside	TLX Fair Value	TLX Upside
Bayesian DCF	Intrinsic	$5.58	-52.3%	$2.81	-70.5%
Earnings Power Value	Intrinsic	—	—	$1.36	-87.7%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$4.63	-60.4%	$0.61	-93.7%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for TENX vs TLX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TENX vs TLX — Which Stock Is More Undervalued?

TENX scores higher with a 4.5/10 quality rating vs TLX's 3.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Tenax Therapeutics, Inc. (TENX) and Telix Pharmaceuticals Limited (TLX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TENX currently trades at $11.69 with a QOC of 4.5/10, while TLX trades at $9.53 with a QOC of 3.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).